Related references
Note: Only part of the references are listed.Protective effect of Lactobacillus plantarum 21, a probiotic on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats
C. S. V. Satish Kumar et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
A new Lactobacillus plantarum strain, TN8, from the gastro intestinal tract of poultry induces high cytokine production
Riadh Ben Salah et al.
ANAEROBE (2012)
Interactions Between the Microbiota and the Immune System
Lora V. Hooper et al.
SCIENCE (2012)
Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis
David Philippe et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2011)
Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice
In-Ah Lee et al.
INFLAMMATION RESEARCH (2010)
Evaluation of adhesion capacity, cell surface traits and immunomodulatory activity of presumptive probiotic Lactobacillus strains
Charalambos Kotzamanidis et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2010)
The application of probiotic fermented milks in cancer and intestinal inflammation
Alejandra de Moreno de LeBlanc et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2010)
Lactobacillus fermentum CECT 5716 Prevents and Reverts Intestinal Damage on TNBS-induced Colitis in Mice
Josep Mane et al.
INFLAMMATORY BOWEL DISEASES (2009)
Therapeutic effects of four strains of probiotics on experimental colitis in mice
Lin-Lin Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice
Hye-Sung Lee et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases
C. D. Packey et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats
Mark S. Geier et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2007)
Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats
Hariom Yadav et al.
NUTRITION (2007)
The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model
Antonio Ramon Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis
T Vowinkel et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats
G Rumi et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance
J McCarthy et al.
GUT (2003)
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2003)
Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment
LA Dieleman et al.
GUT (2003)
Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells
F Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease
RJ Kennedy et al.
BRITISH JOURNAL OF SURGERY (2000)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)